December 11 | 2017
Large interest in the newly launched clinical trial for 2cureX’s IndiTreat™ test
Read more
November 29 | 2017
2cureX prepares for market launch of IndiTreat™ in 2020 – international Chief Business Officer is recruited to lead the process
Read more
November 24 | 2017
2cureX AB: Första dag för handel på Nasdaq Stockholm First North
Read more
November 22 | 2017
2cureX AB: Godkänt för notering på Nasdaq Stockholm First North
Read more
November 2 | 2017
2cureX AB: rights issue ahead of the planned listing on the Nasdaq OMX Stockholm First North was heavily oversubscribed
Read more
November 2 | 2017
2cureX AB: Nyemissionen inför planerad notering på Nasdaq Stockholm First North kraftigt övertecknad
Read more